Royalty Pharma Balance Sheet (2019-2026)

Reported Financials

Royalty Pharma Quarterly Balance Sheet

Periods 29 quarters

Latest Jun 2026

Royalty Pharma reported total assets of $19.82B and total liabilities of $10.03B for the quarter ended Jun 2026, up 8.2% year over year. This balance sheet covers 29 quarters of results from Jun 2019 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance Sheet	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026	Jun2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv.	1.80B	1.54B	1.79B	2.11B	0.99B	1.71B	1.98B	2.17B	0.94B	0.48B	0.84B	1.76B	0.95B	0.93B	1.09B	0.63B	0.94B	0.62B	0.59B	0.81B
Short-term InvestmentsInvestments (Current)	0.25B	0.58B	0.48B	0.36B	0.41B	0.02B	0.00B	0.01B	0.01B	0.02B	0.03B	0.04B	0.05B	0.06B	0.01B	0.01B	0.02B	0.02B	0.02B	0.03B
Cash & Current Investments	2.05B	2.12B	2.28B	2.47B	1.40B	1.74B	1.98B	2.18B	0.94B	0.50B	0.87B	1.80B	1.00B	0.99B	1.10B	0.65B	0.96B	0.64B	0.61B	0.84B
Receivables - OtherOther Receivables	0.06B	0.05B	0.05B	0.02B	0.02B	0.02B	0.02B	0.02B	0.02B	0.01B
Prepaid Assets	0.01B	0.01B	0.01B	0.07B	0.09B	0.09B	0.00B	0.01B	0.01B	0.02B	0.01B	0.00B	0.00B	0.00B	0.00B	0.00B	0.01B	0.01B	0.01B	0.01B
Current Assets	2.78B	2.88B	2.98B	3.50B	2.34B	2.55B	2.63B	2.95B	1.73B	1.27B	1.56B	2.58B	1.79B	1.80B	1.84B	1.52B	1.85B	1.53B	1.43B	1.76B
Non-Current Assets
Long-Term Investments	0.47B	0.44B	0.42B	0.41B	0.41B	0.40B	0.38B	0.38B	0.38B	0.44B	0.47B	0.63B	0.66B	0.69B	0.34B	0.28B	0.30B	0.42B	0.41B	0.37B
Goodwill																0.92B	0.92B	0.92B	0.92B	0.92B
Intangibles	0.01B	0.01B
Goodwill & Intangibles	0.01B	0.01B														0.92B	0.92B	0.92B	0.92B	0.92B
Other Non-Current Assets	0.00B	0.00B	0.00B	0.03B	0.03B	0.03B	0.03B	0.03B	0.02B	0.01B	0.00B	0.03B	0.04B	0.03B	0.04B	0.09B	0.09B	0.08B	0.08B	0.06B
Non-Current Assets	14.96B	14.64B	14.40B	14.24B	15.33B	14.26B	14.44B	14.17B	14.13B	15.11B	14.57B	15.08B	16.25B	16.42B	15.77B	16.80B	17.50B	18.09B	18.39B	18.06B
Assets	17.73B	17.52B	17.38B	17.74B	17.67B	16.81B	17.07B	17.12B	15.86B	16.38B	16.13B	17.66B	18.04B	18.22B	17.61B	18.32B	19.35B	19.62B	19.82B	19.82B
Liabilities
Current Liabilities
Accounts Payables	0.01B	0.01B	0.01B	0.01B	0.02B	0.01B	0.01B	0.01B	0.01B	0.02B	0.01B	0.02B	0.02B	0.01B	0.04B	0.02B	0.04B	0.02B	0.03B	0.04B
Notes Payables	0.12B	0.11B	0.12B	0.12B	0.11B	0.09B	0.10B
Payables	0.13B	0.11B	0.12B	0.13B	0.12B	0.10B	0.11B	0.01B	0.01B	0.02B	0.01B	0.02B	0.02B	0.01B	0.04B	0.02B	0.04B	0.02B	0.03B	0.04B
Accumulated Expenses	0.02B	0.06B	0.01B	0.05B	0.01B	0.05B	0.01B	0.05B	0.01B	0.05B	0.01B	0.06B	0.04B	0.10B	0.02B	0.09B	0.03B	0.11B	0.03B	0.11B
Other Accumulated Expenses						0.01B				0.01B	0.01B	0.10B	0.03B	0.07B	0.02B	0.00B	0.00B	0.05B	0.02B	0.02B
Short term Debt					1.00B	1.00B	1.00B	1.00B					1.00B	1.00B	1.00B	1.00B	0.38B	0.38B	0.38B	0.38B
Total Current Liabilities	0.26B	0.17B	0.14B	0.18B	1.13B	1.17B	1.12B	1.17B	0.13B	0.16B	0.12B	0.28B	1.17B	1.25B	1.18B	1.21B	0.53B	0.64B	0.54B	0.63B
Non-Current Liabilities
Non-Current Debt	7.09B	7.10B	7.10B	7.11B	7.11B	7.12B	7.12B	7.13B	6.13B	6.14B	6.14B	7.60B	7.61B	7.61B	7.62B	8.00B	8.95B	8.95B	8.96B	8.96B
Minority Interest	4.59B	4.47B	4.36B	4.38B	4.26B	3.90B	3.87B	3.53B	3.45B	3.56B	3.36B	3.28B	3.39B	3.40B	3.10B	3.16B	3.21B	3.24B	3.05B	2.95B
Other Non-Current Liabilities				0.04B	0.01B	0.00B	0.01B	0.01B	0.01B	0.00B	0.00B	0.03B	0.01B	0.01B	0.02B	0.47B	0.50B	0.58B	0.65B	0.71B
Total Non-Current Liabilities		7.27B		7.29B	7.25B	7.29B	7.24B	7.30B	6.26B	6.30B	6.26B	7.88B	7.78B	7.87B	7.80B	8.35B	9.22B	9.33B	9.23B	9.32B
Total Liabilities	7.35B	7.27B	7.24B	7.33B	7.26B	7.29B	7.25B	7.31B	6.27B	6.30B	6.27B	7.90B	7.78B	7.88B	7.82B	8.82B	9.73B	9.91B	9.88B	10.03B
Shareholder's Equity
Total Debt	7.21B	7.20B	7.22B	7.22B	8.21B	8.21B	8.22B	8.13B	6.13B	6.14B	6.14B	7.60B	8.60B	8.61B	8.62B	9.00B	9.33B	9.33B	9.34B	9.34B
Common Equity	10.39B	10.25B	10.14B	10.41B	10.42B	9.53B	9.82B	9.81B	9.59B	10.08B	9.86B	9.75B	10.26B	10.34B	9.78B	9.49B	9.62B	9.71B	9.94B	9.79B
Liabilities and Shareholders Equity	17.73B	17.52B	17.38B	17.74B	17.67B	16.81B	17.07B	17.12B	15.86B	16.38B	16.13B	17.66B	18.04B	18.22B	17.61B	18.32B	19.35B	19.62B	19.82B	19.82B
Treasury Shares	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B
Retained Earnings	3.45B	3.51B	3.54B	3.57B	3.63B	3.67B	3.74B	4.03B	4.01B	4.01B	4.07B	4.10B	4.11B	4.10B	4.21B	4.13B	4.11B	4.12B	4.38B	4.38B

Royalty Pharma RPRX Balance Sheet (2019-2026)

Royalty Pharma Quarterly Balance Sheet

Create an account

Sign In

Reset Password